BCRX · Biocryst Pharmaceuticals Inc · Executive Compensation
$7.32
+0.02 (+0.27%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.88B
Shares
257.30M
Volume · Nov 19
3.78M
Avg daily vol (3M)
4.93M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jon P. Stonehouse | Former President and Chief Executive Officer | $12,951,082 |
| Charles Gayer | President and Chief Executive Officer; Former Chief Commercial Officer | $9,627,868 |
| Babar Ghias | Chief Financial Officer | $6,748,152 |
| Alane P. Barnes | Chief Legal Officer and Corporate Secretary | $5,616,032 |
| Helen Thackray | Former Chief R&D Officer | $4,339,624 |
| Anthony Doyle | Former Chief Financial Officer and Treasurer | $2,141,135 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jon P. Stonehouse | President, Chief Executive Officer, Interim Chief Financial Officer, and Director | $8,317,286 |
| Helen Thackray | Chief R&D Officer | $3,568,850 |
| Charles Gayer | Chief Commercial Officer | $3,375,210 |
| Anthony Doyle | Former Chief Financial Officer and Treasurer | $3,287,271 |
| Alane P. Barnes | Chief Legal Officer and Corporate Secretary | $3,241,696 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jon P. Stonehouse | President, Chief Executive Officer, Interim Chief Financial Officer, and Director | $4,777,778 |
| Helen Thackray | Chief R&D Officer | $2,393,933 |
| Alane P. Barnes | Chief Legal Officer and Corporate Secretary | $1,932,072 |
| Anthony Doyle | Former Chief Financial Officer and Treasurer | $1,790,349 |
| Charles Gayer | Chief Commercial Officer | $1,738,544 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jon P. Stonehouse | President, Chief Executive Officer, Interim Chief Financial Officer, and Director | $6,982,994 |
| Helen Thackray | Chief R&D Officer | $3,497,932 |
| William P. Sheridan | MBBS Chief Development Officer | $2,658,421 |
| Yarlagadda S. Babu | Chief Discovery Officer | $2,565,782 |
| Anthony Doyle | Former Chief Financial Officer and Treasurer | $2,281,851 |
| Alane P. Barnes | Chief Legal Officer and Corporate Secretary | $2,210,762 |
| Charles Gayer | Chief Commercial Officer | $2,198,862 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Megan Sniecinski | Former Chief Business Officer | $7,929,124 |
| Jon P. Stonehouse | President, Chief Executive Officer and Director | $7,061,225 |
| Helen Thackray | Chief R&D Officer | $6,881,396 |
| Anthony Doyle | Chief Financial Officer and Treasurer | $2,890,803 |
| William P. Sheridan | MBBS Chief Development Officer | $2,531,231 |
| Yarlagadda S. Babu | Chief Discovery Officer | $2,386,139 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jon P. Stonehouse | President, Chief Executive Officer and Director | $6,034,941 |
| Anthony Doyle | Chief Financial Officer and Treasurer | $4,117,930 |
| William P. Sheridan | MBBS Chief Development Officer | $2,679,920 |
| Yarlagadda S. Babu | Chief Discovery Officer | $2,264,785 |
| Megan Sniecinski | Former Chief Business Officer | $2,012,335 |
| Thomas R. Staab II | Former Senior Vice President and Chief Financial Officer | $692,790 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jon P. Stonehouse | President, Chief Executive Officer and Director | $2,284,297 |
| Megan Sniecinski | Former Chief Business Officer | $2,176,954 |
| Yarlagadda S. Babu | Chief Discovery Officer | $1,083,307 |
| William P. Sheridan | MBBS Chief Medical Officer | $1,067,183 |
| Thomas R. Staab II | Former Senior Vice President and Chief Financial Officer | $910,354 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jon P. Stonehouse | President, Chief Executive Officer and Director | $4,167,643 |
| William P. Sheridan | MBBS Chief Medical Officer | $2,349,219 |
| Thomas R. Staab II | Former Senior Vice President and Chief Financial Officer | $1,797,270 |
| Yarlagadda S. Babu | Chief Discovery Officer | $1,755,510 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Jon P. Stonehouse | President, Chief Executive Officer and Director | $3,921,189 |
| William P. Sheridan | Senior Vice President and Chief Medical Officer | $1,808,550 |
| Thomas R. Staab II | Senior Vice President and Chief Financial Officer | $1,723,588 |
| Drug Discovery | — | $1,639,444 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Amy E. McKee, M.D. | director | Appointed | 2026-06-12 |
| Jon P. Stonehouse | director | Appointed | 2026-06-12 |
| Theresa M. Heggie | director |
Already on the board
Since at least 2018: re-election or new board role
|
2026-06-12 |
| Jill C. Milne | member of the board of directors of Parent | Appointed | 2025-10-14 |
|
Dr. Helen Thackray
“Dr. Thackray cited no disagreement with the Board of Directors (the “Board”) or management relating to the Company, its operations, policies, or practices.”
|
Chief Research and Development Officer | Resigned | 2025-08-11 |
| Charlie Gayer | director | Appointed | 2025-07-31 |
| Charlie Gayer | Chief Executive Officer | Appointed | 2025-07-31 |
| Charlie Gayer | President | Appointed | 2025-07-31 |
|
Jon Stonehouse
“Mr. Stonehouse cited no disagreement with the Board or management relating to the Company, its operations, policies, or practices, and he will continue to serve as a member of the Board following his retirement.”
|
President and Chief Executive Officer | Retired | 2025-07-31 |
| Babar Ghias | Principal Accounting Officer | Appointed | 2025-07-07 |
| Babar Ghias | Chief Financial Officer | Appointed | 2025-07-07 |
|
George B. Abercrombie
“Mr. Abercrombie cited no disagreement with the Board or management relating to the Company, its operations, policies, or practices.”
|
Board of Directors | Retired | 2025-06-16 |
| Steven Frank | director | Appointed | 2025-05-01 |
| Jon P. Stonehouse | Interim Chief Financial Officer and Interim Principal Accounting Officer | Appointed | 2025-04-10 |
| Jon P. Stonehouse | Interim Principal Accounting Officer | Appointed | 2025-04-10 |
| Anthony Doyle | Interim Principal Accounting Officer | Resigned | 2025-04-10 |
| Anthony Doyle | Chief Financial Officer and Interim Principal Accounting Officer | Resigned | 2025-04-10 |
|
Anthony Doyle
“Mr. Doyle’s resignation from the Company is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.”
|
Chief Financial Officer | Resigned | 2025-03-04 |
| A. Machelle Sanders | director |
Already on the board
Since at least 2022: re-election or new board role
|
2024-06-13 |
| Vincent J. Milano | director |
Already on the board
Since at least 2021: re-election or new board role
|
2024-06-13 |
| Nancy J. Hutson | director |
Already on the board
Since at least 2012: re-election or new board role
|
2024-06-13 |
|
Kenneth B. Lee, Jr.
“Mr. Lee cited no disagreement with the Board or management relating to the Company, its operations, policies, or practices.”
|
Board of Directors | Retired | 2023-12-01 |
|
Michael L. Jones
“His resignation is not due to any disagreement on any matter relating to the Company’s operations, policies, or practices.”
|
Executive Director, Finance and Principal Accounting Officer | Resigned | 2023-07-11 |
| Jon P. Stonehouse | director | Appointed | 2023-06-14 |
| Amy E. McKee, M.D. | director | Appointed | 2023-06-14 |
Leadership
- Charles Gayer CEO, Board Member
- Charlie Gayer CEO, Board Member
- Vincent J. Milano Chairman, Board Member
- Babar Ghias CFO, Chief Accounting Officer
- Jon P. Stonehouse CFO, Chief Accounting Officer, Board Member
- Thomas R. Staab II CFO
- A. Machelle Sanders Board Member
- Alan G. Levin Board Member
- Amy E. McKee Board Member
- Amy E. McKee, M.D. Board Member
- Amy McKee Board Member
- Amy McKee, M.D. Board Member
- George B. Abercrombie Board Member
- Jill C. Milne Board Member
- Jill C. Milne, Ph.D. Board Member
- Jon Stonehouse Board Member
- Machelle Sanders Board Member
- Steven Frank Board Member
- Steven Galson Board Member
- Steven Galson, M.D. Board Member
- Steven K. Galson Board Member
- Steven K. Galson, M.D., MPH Board Member
- Steven R. Frank Board Member
- Theresa M. Heggie Board Member
Key facts
CIK
882796
CUSIP
09058V103
13F (30d)
344 filings
320 filers
Visit website
Investor relations